x
Filter:
Filters applied
- IASLC Staging Articles
- Nowak, AnnaRemove Nowak, Anna filter
- MesotheliomaRemove Mesothelioma filter
Author
- Pass, Harvey2
- Rice, David2
- Rusch, Valerie W2
- Asamura, Hisao1
- Atinkaya, Cansel1
- Call, Sergi1
- Cangir, Ayten K1
- Chansky, Kari1
- Edwards, John1
- Giroux, Dorothy1
- Hasegawa, Seiki1
- Hoffmann, Hans1
- Kennedy, Catherine1
- Kernstine, Kemp1
- Kindler, Hedy1
- Nafteux, Philippe1
- Opitz, Isabelle1
- Rea, Federico1
- Ruffini, Enrico1
- Shemanski, Lynn1
- van Meerbeeck, Jan P1
- Waller, David1
- Weder, Walter1
IASLC Staging Articles
2 Results
- Original Article IASLC Staging Committee Article
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
Journal of Thoracic OncologyVol. 11Issue 12p2100–2111Published online: September 26, 2016- David Rice
- Kari Chansky
- Anna Nowak
- Harvey Pass
- Hedy Kindler
- Lynn Shemanski
- and others
Cited in Scopus: 81Nodal categories for malignant pleural mesothelioma are derived from the lung cancer staging system and have not been adequately validated. The International Association for the Study of Lung Cancer developed a multinational database to generate evidence-based recommendations to inform the eighth edition of the TNM classification of malignant pleural mesothelioma. - Original Article IASLC Staging Committee ArticleOpen Archive
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation
Journal of Thoracic OncologyVol. 11Issue 12p2082–2088Published online: September 23, 2016- Harvey Pass
- Dorothy Giroux
- Catherine Kennedy
- Enrico Ruffini
- Ayten K. Cangir
- David Rice
- and others
Cited in Scopus: 48For nearly 40 years, there was no generally accepted staging system for malignant pleural mesothelioma. In 1994, members of the International Mesothelioma Interest Group, in collaboration with the International Association for the Study of Lung Cancer, proposed a TNM staging system based on analyses of outcomes in retrospective surgical series and small clinical trials. Subsequently accepted by the American Joint Commission on Cancer and the Union for International Cancer Control for the sixth editions of their staging manuals, this system has since been the international staging standard.